Anesthesia Medical News about Hyperalgesia Opiate Alkaloids Receptors, Chemokine

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Opiate-induced hypernociception and chemokine receptors
Neuropharmacology, 11/10/09

White F et al. – Opiates, such as morphine, are typically employed to alleviate acute or chronic pain states. However, there are a myriad of side effects including constipation, nausea, respiratory depression, cough suppression, vomiting, sedation, addiction and tolerance. It has also been reported experimentally and clinically that exposure to opiate can elicit paradoxical pain (opiate–induced tactile hyperalgesia; OIH) in regions of the body unrelated to the initial pain complaint. Several mechanisms have been suggested to be responsible for OIH such as sensitization of peripheral nociceptors, enhanced production/release of glutamate and neuropeptides in the spinal cord, protein kinase C gamma–induced signaling, and/or enhanced descending facilitation of nociceptive pathways from the rostral ventromedial medulla; however signaling pathways known to lead to directly to OIH remain undiscovered. Recent publications from this laboratory and others have discovered a potentially important link to OIH that involves the chemokine (chemotactic cytokine), stromal–derived factor 1 (SDF1 also known as CXCL12) and its cognate receptor CXCR4.

<< Previous
Clarithromycin, a potent inhibitor of CYP3A, greatly increases...

Next >>
Boomers send health spending booming